Everence Capital Management’s Xylem XYL Stock Holding History

Everence Capital Management’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.78M	Hold	14,930	–	–	0.11%	155
2025 Q4	$2.03M	Hold	14,930	–	–	0.12%	134
2025 Q3	$2.2M	Hold	14,930	–	–	0.13%	128
2025 Q2	$1.93M	Sell	14,930 -1,800	-11%	-$218K	0.12%	142
2025 Q1	$2M	Hold	16,730	–	–	0.14%	135
2024 Q4	$1.94M	Sell	16,730 -120	-0.7%	-$15.2K	0.13%	135
2024 Q3	$2.27M	Hold	16,850	–	–	0.14%	123
2024 Q2	$2.2K	Hold	16,850	–	–	0.15%	119
2024 Q1	$2.18K	Hold	16,850	–	–	0.14%	137
2023 Q4	$1.93M	Sell	16,850 -4,060	-19%	-$405K	0.14%	141
2023 Q3	$1.9K	Buy	20,910 +3,290	+19%	+$339K	0.15%	124
2023 Q2	$1.77M	Hold	17,620	–	–	0.14%	125
2023 Q1	$1.84K	Buy	17,620 +2,960	+20%	+$309K	0.15%	120
2022 Q4	$1.62K	Hold	14,660	–	–	0.14%	136
2022 Q3	$1.28M	Hold	14,660	–	–	0.12%	151
2022 Q2	$1.15M	Hold	14,660	–	–	0.1%	169
2022 Q1	$1.25M	Buy	14,660 +1,050	+8%	+$101K	0.1%	176
2021 Q4	$1.63M	Hold	13,610	–	–	0.12%	150
2021 Q3	$1.68M	Hold	13,610	–	–	0.14%	129
2021 Q2	$1.63M	Hold	13,610	–	–	0.13%	130
2021 Q1	$1.43M	Hold	13,610	–	–	0.13%	136
2020 Q4	$1.39M	Buy	13,610 +180	+1%	+$16.9K	0.14%	128
2020 Q3	$1.13M	Buy	13,430 +7,810	+139%	+$608K	0.12%	139
2020 Q2	$373K	Hold	5,620	–	–	0.04%	390
2020 Q1	$366K	Hold	5,620	–	–	0.05%	326
2019 Q4	$443K	Sell	5,620 -3,720	-40%	-$290K	0.07%	331
2019 Q3	$744K	Hold	9,340	–	–	0.12%	181
2019 Q2	$781K	Hold	9,340	–	–	0.13%	166
2019 Q1	$738K	Sell	9,340 -583	-6%	-$42.5K	0.13%	173
2018 Q4	$662K	Hold	9,923	–	–	0.15%	162
2018 Q3	$793K	Hold	9,923	–	–	0.16%	160
2018 Q2	$669K	Buy	9,923 +3,860	+64%	+$280K	0.14%	176
2018 Q1	$466K	Hold	6,063	–	–	0.1%	231
2017 Q4	$413K	Hold	6,063	–	–	0.09%	249
2017 Q3	$380K	Hold	6,063	–	–	0.09%	260
2017 Q2	$336K	Hold	6,063	–	–	0.08%	270
2017 Q1	$304K	Hold	6,063	–	–	0.08%	274
2016 Q4	$300K	Sell	6,063 -1,495	-20%	-$75.8K	0.09%	270
2016 Q3	$396K	Hold	7,558	–	–	0.12%	213
2016 Q2	$337K	Sell	7,558 -3,040	-29%	-$132K	0.1%	227
2016 Q1	$433K	Hold	10,598	–	–	0.13%	202
2015 Q4	$387K	Hold	10,598	–	–	0.13%	206
2015 Q3	$348K	Hold	10,598	–	–	0.12%	216
2015 Q2	$393K	Hold	10,598	–	–	0.13%	208
2015 Q1	$378K	Hold	10,598	–	–	0.13%	209
2014 Q4	$403K	Hold	10,598	–	–	0.14%	202
2014 Q3	$395K	Hold	10,598	–	–	0.14%	187
2014 Q2	$414K	Hold	10,598	–	–	0.15%	186
2014 Q1	$386K	Hold	10,598	–	–	0.15%	191
2013 Q4	$367K	Hold	10,598	–	–	0.15%	189
2013 Q3	$296K	Buy	+10,598	New	+$283K	0.13%	199

Other funds holding XYL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Everence Capital Management's XYL Position: Q1 2026 in Review

Everence Capital Management held its Xylem (XYL) position steady in Q1 2026 at 14,930 shares worth $1.78M. The position accounts for 0.11% of the portfolio, ranked #155.

Everence Capital Management first reported a position in XYL in Q3 2013 and has held it in 51 quarters since. The position peaked at $2.27M in Q3 2024. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

Everence Capital Management held 14,930 shares of Xylem worth $1.78M as of Q1 2026.
Everence Capital Management left its Xylem share count unchanged in Q1 2026.
Xylem made up 0.11% of Everence Capital Management's portfolio in Q1 2026, its #155 holding.
Everence Capital Management first reported a position in Xylem in Q3 2013 and has held it in 51 quarters since.
Everence Capital Management's Xylem position peaked at $2.27M in Q3 2024.
1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.